- £255.94m
- £796.58m
- $1.18bn
- 45
- 98
- 60
- 81
Annual income statement for Enquest, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 864 | 1,266 | 1,854 | 1,487 | 1,181 |
| Cost of Revenue | |||||
| Gross Profit | 76.5 | 366 | 653 | 541 | 393 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,174 | 686 | 1,476 | 1,090 | 869 |
| Operating Profit | -310 | 580 | 378 | 397 | 312 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -566 | 352 | 203 | 232 | 167 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -470 | 377 | 185 | 85.6 | 93.8 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -470 | 377 | -41.2 | -30.8 | 93.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -470 | 377 | -41.2 | -30.8 | 93.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.075 | 0.229 | 0.303 | 0.148 | 0.126 |
| Dividends per Share |